Icelandic venture capital firm Brunnur Ventures leads funding round to support development of breakthrough lipid nanoparticle delivery technologies BROOKLINE, MA, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Axelyf, Inc., a biotechnology company developing next-generation lipid nanoparticle (LNP) delivery systems for RNA therapeutics, today announced the closing of $2.6 million in seed funding, with the potential to reach a total of $4.1 million this fall.